Clinical trial
Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light…
NCT00280501 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00280501 |
|---|---|
| Title | Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions |
| Official title | Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Regional Blood Flow, Ocular Physiology |
| Intervention type | Drug |
| Interventions | Quetiapine (drug), Sulpiride (drug), Placebo |
| Enrollment | 21 |
| Start date | Aug 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jan 23, 2006 |
| Last update posted | Jul 9, 2008 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: